Beran M - Search Results

1

Diagnosis and management of chronic myelomonocytic leukemia.

Onida F, Beran M. Onida F, et al. Among authors: beran m. Curr Hematol Malig Rep. 2008 Jan;3(1):31-6. doi: 10.1007/s11899-008-0006-x. Curr Hematol Malig Rep. 2008. PMID: 20425444

2

Chronic myelomonocytic leukemia: myeloproliferative variant.

Onida F, Beran M. Onida F, et al. Among authors: beran m. Curr Hematol Rep. 2004 May;3(3):218-26. Curr Hematol Rep. 2004. PMID: 15087071 Review.

3

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.

Ricci C, Fermo E, Corti S, Molteni M, Faricciotti A, Cortelezzi A, Lambertenghi Deliliers G, Beran M, Onida F. Ricci C, et al. Among authors: beran m. Clin Cancer Res. 2010 Apr 15;16(8):2246-56. doi: 10.1158/1078-0432.CCR-09-2112. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371679 Free article.

4

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.

Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH, Glassman AB, Albitar M, Kwari MI, Beran M. Onida F, et al. Among authors: beran m. Blood. 2002 Feb 1;99(3):840-9. doi: 10.1182/blood.v99.3.840. Blood. 2002. PMID: 11806985 Free article.

5

In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.

Scappini B, Onida F, Kantarjian HM, Dong L, Verstovsek S, Keating MJ, Beran M. Scappini B, et al. Among authors: beran m. Cancer. 2002 May 15;94(10):2653-62. doi: 10.1002/cncr.10543. Cancer. 2002. PMID: 12173333 Free article.

6

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.

Beran M, Wen S, Shen Y, Onida F, Jelinek J, Cortes J, Giles F, Kantarjian H. Beran M, et al. Leuk Lymphoma. 2007 Jun;48(6):1150-60. doi: 10.1080/10428190701216386. Leuk Lymphoma. 2007. PMID: 17577778

7

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M. Mittal P, et al. Among authors: beran m. Bone Marrow Transplant. 2004 May;33(10):1005-9. doi: 10.1038/sj.bmt.1704472. Bone Marrow Transplant. 2004. PMID: 15048141

8

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.

Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M. Onida F, et al. Among authors: beran m. Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832. Cancer. 2002. PMID: 12365015 Free article.

9

Prognostic significance of monocytosis in patients with myeloproliferative disorders.

Beran M, Shen Y, Onida F, Wen S, Kantarjian H, Estey E. Beran M, et al. Leuk Lymphoma. 2006 Mar;47(3):417-23. doi: 10.1080/10428190500305448. Leuk Lymphoma. 2006. PMID: 16396764

10

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.

Scappini B, Gatto S, Onida F, Ricci C, Divoky V, Wierda WG, Andreeff M, Dong L, Hayes K, Verstovsek S, Kantarjian HM, Beran M. Scappini B, et al. Among authors: beran m. Cancer. 2004 Apr 1;100(7):1459-71. doi: 10.1002/cncr.20131. Cancer. 2004. PMID: 15042680 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

619 results

Search Page

Filters